Cargando…
The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer
Background. Aberrant promoter methylation has been considered as a potential molecular marker for gastric cancer (GC). However, the role of methylation of FLNC, THBS1, and UCHL1 in the development and progression of GC has not been explored. Methods. The promoter methylation status of UCHL1, FLNC, T...
Autores principales: | Wang, Gongping, Zhang, Wei, Zhou, Bo, Jin, Canhui, Wang, Zengfang, Yang, Yantong, Wang, Zhenzhen, Chen, Ye, Feng, Xiaoshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624918/ https://www.ncbi.nlm.nih.gov/pubmed/26550574 http://dx.doi.org/10.1155/2015/741030 |
Ejemplares similares
-
Expression of GOLPH3 protein in colon cancer tissues and its association with the prognosis of patients
por: Zhou, Bo, et al.
Publicado: (2016) -
Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls
por: Qiao, Lele, et al.
Publicado: (2018) -
UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis
por: Li, Ruibing, et al.
Publicado: (2020) -
Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
por: Hu, Yilin, et al.
Publicado: (2019) -
Molecular Characterization and Expression Profiles of Sp-uchl3 and Sp-uchl5 during Gonad Development of Scylla paramamosain
por: Han, Kunhuang, et al.
Publicado: (2018)